Dr. Scangos has been the President and Chief Executive officer of Exelixis, Inc. since he joined the company in October 1996. Dr. Scangos began his career on the faculty of the Johns Hopkins University, where he now holds an appointment as Adjunct Professor of Biology. He left Hopkins in 1986 to work for Bayer Corporation, where he held several positions, including Senior Vice President of Research and Development for Bayer's pharmaceutical division, and then President of Bayer Biotechnology. Dr. Scangos serves on the Boards of Directors of Anadys Pharmaceuticals, Entelos, Inc., as well as Exelixis. He serves on the Board of Visitors at the University of California, San Francisco School of Pharmacy, the Board of Overseers at the University of California, Davis Medical School, and the Advisory Board for the Cornell University Life Sciences Initiative. Dr. Scangos received a BA from Cornell University, a Ph.D. in Microbiology from the University of Massachusetts, and was a Jane Coffin Childs Postdoctoral Fellow in the laboratory of Frank Ruddle at Yale University.